期刊文献+

曲安奈德在玻璃体视网膜手术中的应用 被引量:12

The application of the triamcinolone acetonide injection in vitreoretinal surgery
原文传递
导出
摘要 目的观察曲安奈德(TA)注射液在玻璃体视网膜手术中协助辨别和清除残留玻璃体皮质的作用及效果。方法2003年8月至2005年2月,对在玻璃体视网膜手术术前和手术中未发现明确玻璃体后脱离的1046例1056只眼,经大部分玻璃体切除后,玻璃体内注射TA混悬液约1~2mg,对后极部视网膜表面可能残存的玻璃体皮质进行标识,将粘附TA的玻璃体皮质完全剥除。结果乳白色的TA粘附在玻璃体皮质上可清楚地显示附着于视网膜表面的残留玻璃体皮质的部位及范围,使之容易辨认并易于剥除。结论TA在玻璃体视网膜手术中的应用有助于辨别残留的玻璃体皮质,提高彻底清除玻璃体皮质的手术效率及成功率。 Objective To discuss the role and effect of the triamcinolone acetonide (TA) injection applied in the vitreoretinal surgery for assisting to distinguish and removal residual cortex. Methods One thousand and forty-six patients ((1 056) eyes) underwent a PPV at West China Eye Center from August 2003 to February 2005. These affected eyes were selected without posterior vitreous detachment pre- and intra-operatively, and underwent intravitreal injection with TA 1-2 mg to label the residual vitreous cortex on the surface of the posterior retina after removal of the majority vitreous. Results The location and coverage of the residual vitreous cortex were clearly be shown by the white appearance of TA labeled residual vitreous, and the residual vitreous cortex was conveniently to be recognized and removed. Conclusion The application of intravitreal injection with TA is helpful for identification and elimination of the residual vitreous cortex in vitreoretinal surgery.
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2005年第4期226-228,共3页 Chinese Journal of Ocular Fundus Diseases
关键词 曲安奈德 玻璃体切除术 TA 视网膜手术 玻璃体皮质 Triamcinolone acetonide/therapeutic use Vitrectomy
  • 相关文献

参考文献6

  • 1Peyman GA, Cheema R, Conway MD, et al. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina, 2000,20: 554-555.
  • 2Sakamoto T,Miyazaki M,Hisatomi T,et al. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown.Graefes Arch Clin Exp Ophthalmol, 2002,240: 423-429.
  • 3刘谊,严密.曲安奈德玻璃体腔注射的临床应用[J].中华眼底病杂志,2003,19(4):263-265. 被引量:89
  • 4Ozkiris A, Erkilic K. Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol, 2005,40: 63-68.
  • 5Takeuchi M, Katagiri Y, Usui M. Residual triamcinolone acetonide in the macular hole after vitrectomy. Am J Ophthalmol,2003,136:1174-1176.
  • 6Enaida H, Sakamoto T, Ueno A, et al. Submacular deposition of triamcinolone acetonide after triamcinolone-assisted vitrectomy.Am J Ophthalmol, 2003,135:243-246.

二级参考文献4

  • 1Jost B. Jonas,Ingrid Kreissig,Robert F. Degenring. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion[J] 2002,Graefe’s Archive for Clinical and Experimental Ophthalmology(9):782~783
  • 2Taiji Sakamoto,Miho Miyazaki,Toshio Hisatomi,Takao Nakamura,Akifumi Ueno,Keiko Itaya,Tatsuro Ishibashi. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood–ocular barrier breakdown[J] 2002,Graefe’s Archive for Clinical and Experimental Ophthalmology(6):423~429
  • 3Yu-sheng Wang,Ulrike Friedrichs,Wolfram Eichler,Stephan Hoffmann,Peter Wiedemann. Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells[J] 2002,Graefe’s Archive for Clinical and Experimental Ophthalmology(1):42~48
  • 4Yan-Nian Hui,Hou-Cheng Liang,Yong-Shu Cai,Bernd Kirchhof,Klaus Heimann. Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretionopathy induced by macrophages[J] 1993,Graefe’s Archive for Clinical and Experimental Ophthalmology(2):109~114

共引文献88

同被引文献84

引证文献12

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部